Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors
Apply
Solid Tumors
A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step